Gresham Richter
Concepts (489)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Malformations | 22 | 2023 | 101 | 8.400 |
Why?
| Arteriovenous Malformations | 16 | 2023 | 66 | 7.440 |
Why?
| Hemangioma | 14 | 2022 | 83 | 5.970 |
Why?
| Propranolol | 10 | 2020 | 78 | 3.380 |
Why?
| Lymphatic Abnormalities | 7 | 2020 | 22 | 3.350 |
Why?
| Glottis | 8 | 2020 | 32 | 3.280 |
Why?
| Laryngomalacia | 9 | 2016 | 24 | 3.160 |
Why?
| Infant | 50 | 2021 | 3829 | 2.330 |
Why?
| Neck | 11 | 2022 | 116 | 2.310 |
Why?
| Sclerotherapy | 11 | 2023 | 47 | 2.100 |
Why?
| Child | 53 | 2023 | 7368 | 2.060 |
Why?
| Lasers, Solid-State | 5 | 2020 | 32 | 2.030 |
Why?
| Laryngoscopy | 10 | 2020 | 62 | 1.910 |
Why?
| Deglutition Disorders | 5 | 2017 | 71 | 1.910 |
Why?
| Laryngostenosis | 4 | 2020 | 10 | 1.910 |
Why?
| Child, Preschool | 43 | 2022 | 4158 | 1.890 |
Why?
| Humans | 115 | 2023 | 54391 | 1.790 |
Why?
| Laser Therapy | 6 | 2020 | 91 | 1.660 |
Why?
| Treatment Outcome | 33 | 2023 | 5612 | 1.560 |
Why?
| Vascular Surgical Procedures | 5 | 2020 | 178 | 1.520 |
Why?
| Tonsillectomy | 4 | 2021 | 49 | 1.390 |
Why?
| Veins | 6 | 2023 | 74 | 1.380 |
Why?
| Larynx | 7 | 2017 | 39 | 1.370 |
Why?
| Hemangioma, Capillary | 2 | 2020 | 12 | 1.340 |
Why?
| Embolization, Therapeutic | 6 | 2023 | 98 | 1.290 |
Why?
| Male | 66 | 2021 | 27347 | 1.260 |
Why?
| Female | 65 | 2022 | 28471 | 1.180 |
Why?
| Otolaryngology | 4 | 2021 | 58 | 1.180 |
Why?
| Head | 5 | 2022 | 78 | 1.160 |
Why?
| Retrospective Studies | 32 | 2022 | 6459 | 1.160 |
Why?
| Skin | 5 | 2020 | 469 | 1.060 |
Why?
| Trachea | 5 | 2018 | 51 | 1.010 |
Why?
| Tongue | 4 | 2023 | 41 | 0.950 |
Why?
| Facial Neoplasms | 2 | 2017 | 23 | 0.950 |
Why?
| Ambulatory Surgical Procedures | 2 | 2021 | 52 | 0.940 |
Why?
| Vocal Cord Paralysis | 2 | 2022 | 27 | 0.940 |
Why?
| Otorhinolaryngologic Diseases | 2 | 2014 | 12 | 0.930 |
Why?
| Collagen | 2 | 2019 | 223 | 0.900 |
Why?
| Head and Neck Neoplasms | 5 | 2015 | 336 | 0.890 |
Why?
| Cell Proliferation | 7 | 2023 | 1097 | 0.890 |
Why?
| Adolescent | 27 | 2022 | 6900 | 0.870 |
Why?
| Face | 2 | 2020 | 66 | 0.870 |
Why?
| Health Information Systems | 1 | 2022 | 20 | 0.860 |
Why?
| Surgery, Computer-Assisted | 2 | 2020 | 53 | 0.860 |
Why?
| Respiratory Aspiration | 2 | 2014 | 9 | 0.850 |
Why?
| Adrenergic beta-Antagonists | 4 | 2020 | 105 | 0.840 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2013 | 84 | 0.840 |
Why?
| Hyperpigmentation | 1 | 2021 | 10 | 0.830 |
Why?
| Cricoid Cartilage | 2 | 2020 | 11 | 0.820 |
Why?
| Receptors, Progesterone | 1 | 2021 | 57 | 0.780 |
Why?
| Otorhinolaryngologic Surgical Procedures | 3 | 2014 | 35 | 0.780 |
Why?
| Intracranial Arteriovenous Malformations | 2 | 2019 | 28 | 0.760 |
Why?
| Graft Survival | 4 | 2011 | 165 | 0.760 |
Why?
| Receptors, Estrogen | 1 | 2021 | 131 | 0.760 |
Why?
| Dilatation | 2 | 2017 | 27 | 0.750 |
Why?
| Ambulatory Care Facilities | 1 | 2021 | 138 | 0.750 |
Why?
| Dermatologic Surgical Procedures | 1 | 2020 | 38 | 0.750 |
Why?
| Infant, Newborn | 19 | 2020 | 2923 | 0.710 |
Why?
| Prospective Studies | 8 | 2022 | 2606 | 0.710 |
Why?
| Risk Assessment | 10 | 2018 | 1362 | 0.710 |
Why?
| Tracheostomy | 3 | 2022 | 81 | 0.700 |
Why?
| Elastin | 1 | 2019 | 22 | 0.700 |
Why?
| Inpatients | 1 | 2021 | 206 | 0.690 |
Why?
| Vasodilator Agents | 2 | 2017 | 111 | 0.690 |
Why?
| Skin Transplantation | 3 | 2009 | 50 | 0.690 |
Why?
| Gastroesophageal Reflux | 2 | 2017 | 49 | 0.690 |
Why?
| Thyroid Cartilage | 1 | 2018 | 2 | 0.670 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1141 | 0.670 |
Why?
| Laryngoplasty | 1 | 2018 | 7 | 0.660 |
Why?
| Pharynx | 3 | 2014 | 39 | 0.660 |
Why?
| Vascular Neoplasms | 1 | 2018 | 20 | 0.660 |
Why?
| Follow-Up Studies | 12 | 2018 | 2390 | 0.650 |
Why?
| Vascular Endothelial Growth Factor A | 3 | 2009 | 232 | 0.650 |
Why?
| Mast Cells | 1 | 2018 | 64 | 0.650 |
Why?
| Endoscopy | 6 | 2015 | 131 | 0.640 |
Why?
| Ki-67 Antigen | 3 | 2013 | 63 | 0.630 |
Why?
| Deglutition | 3 | 2014 | 37 | 0.620 |
Why?
| Endovascular Procedures | 1 | 2020 | 186 | 0.620 |
Why?
| Respiratory Tract Infections | 2 | 2020 | 86 | 0.610 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 124 | 0.610 |
Why?
| Eosinophilic Esophagitis | 1 | 2017 | 32 | 0.600 |
Why?
| Estradiol | 1 | 2018 | 219 | 0.600 |
Why?
| Rectum | 1 | 2017 | 52 | 0.600 |
Why?
| Vagina | 1 | 2017 | 47 | 0.600 |
Why?
| Receptors, Adrenergic, beta | 1 | 2017 | 41 | 0.590 |
Why?
| Renin-Angiotensin System | 1 | 2017 | 65 | 0.590 |
Why?
| Disease Models, Animal | 2 | 2013 | 1647 | 0.580 |
Why?
| Laryngeal Neoplasms | 2 | 2015 | 55 | 0.580 |
Why?
| Young Adult | 12 | 2022 | 4318 | 0.580 |
Why?
| Bleomycin | 3 | 2022 | 37 | 0.580 |
Why?
| Ultrasonography, Prenatal | 1 | 2018 | 187 | 0.570 |
Why?
| Nasopharynx | 2 | 2020 | 32 | 0.570 |
Why?
| Cerebral Palsy | 2 | 2014 | 43 | 0.560 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2016 | 64 | 0.560 |
Why?
| Adult | 22 | 2022 | 14207 | 0.550 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2016 | 93 | 0.550 |
Why?
| Sleep Apnea, Obstructive | 2 | 2014 | 65 | 0.540 |
Why?
| Hearing Aids | 5 | 2017 | 62 | 0.540 |
Why?
| Skin Neoplasms | 2 | 2022 | 532 | 0.530 |
Why?
| Blood Coagulation Disorders | 3 | 2020 | 37 | 0.510 |
Why?
| Wound Healing | 2 | 2014 | 228 | 0.510 |
Why?
| Alginates | 1 | 2014 | 9 | 0.500 |
Why?
| Skin Ulcer | 1 | 2014 | 12 | 0.500 |
Why?
| Blotting, Western | 4 | 2021 | 684 | 0.500 |
Why?
| Polysaccharides | 1 | 2014 | 57 | 0.490 |
Why?
| Adenoidectomy | 2 | 2020 | 34 | 0.480 |
Why?
| Silver | 1 | 2014 | 54 | 0.480 |
Why?
| Postoperative Complications | 3 | 2021 | 1035 | 0.480 |
Why?
| Organophosphonates | 1 | 2013 | 5 | 0.480 |
Why?
| Cytosine | 1 | 2013 | 29 | 0.470 |
Why?
| Periodicals as Topic | 1 | 2014 | 65 | 0.460 |
Why?
| Uvula | 1 | 2013 | 9 | 0.450 |
Why?
| Palate | 1 | 2013 | 14 | 0.450 |
Why?
| Nervous System Diseases | 1 | 2014 | 97 | 0.450 |
Why?
| Pharyngeal Diseases | 1 | 2013 | 12 | 0.450 |
Why?
| Signal Transduction | 3 | 2020 | 1752 | 0.450 |
Why?
| Choristoma | 1 | 2013 | 23 | 0.450 |
Why?
| RNA, Messenger | 4 | 2022 | 1203 | 0.450 |
Why?
| Thymus Gland | 1 | 2013 | 45 | 0.440 |
Why?
| Infant, Premature, Diseases | 1 | 2013 | 93 | 0.440 |
Why?
| Endothelial Cells | 3 | 2023 | 294 | 0.440 |
Why?
| Gestational Age | 2 | 2013 | 435 | 0.440 |
Why?
| Surgical Flaps | 2 | 2020 | 135 | 0.430 |
Why?
| Milk Hypersensitivity | 1 | 2012 | 18 | 0.430 |
Why?
| Receptors, Cell Surface | 1 | 2013 | 130 | 0.430 |
Why?
| Sclerosing Solutions | 2 | 2022 | 14 | 0.420 |
Why?
| Lymphangioma, Cystic | 1 | 2011 | 9 | 0.420 |
Why?
| Endothelium, Lymphatic | 1 | 2011 | 13 | 0.420 |
Why?
| Down Syndrome | 1 | 2013 | 100 | 0.410 |
Why?
| Quality of Life | 3 | 2014 | 924 | 0.410 |
Why?
| Pilot Projects | 4 | 2019 | 807 | 0.410 |
Why?
| Laryngeal Diseases | 2 | 2010 | 14 | 0.410 |
Why?
| Antigens, CD | 1 | 2013 | 242 | 0.410 |
Why?
| Mouth | 2 | 2010 | 35 | 0.410 |
Why?
| Papillomavirus Infections | 1 | 2013 | 163 | 0.400 |
Why?
| Milk Proteins | 1 | 2012 | 77 | 0.400 |
Why?
| Microtubule-Associated Proteins | 1 | 2011 | 78 | 0.400 |
Why?
| Tracheoesophageal Fistula | 2 | 2008 | 11 | 0.400 |
Why?
| Clinical Competence | 3 | 2020 | 444 | 0.400 |
Why?
| Homeodomain Proteins | 1 | 2011 | 82 | 0.400 |
Why?
| Laryngeal Mucosa | 1 | 2011 | 5 | 0.400 |
Why?
| Nervous System Physiological Phenomena | 1 | 2010 | 7 | 0.390 |
Why?
| Laryngeal Nerves | 1 | 2011 | 19 | 0.390 |
Why?
| Magnetic Resonance Angiography | 3 | 2018 | 80 | 0.390 |
Why?
| Tumor Suppressor Proteins | 1 | 2011 | 141 | 0.380 |
Why?
| Osseointegration | 3 | 2017 | 34 | 0.380 |
Why?
| Neuromuscular Diseases | 1 | 2011 | 33 | 0.380 |
Why?
| Severity of Illness Index | 6 | 2014 | 1082 | 0.370 |
Why?
| Hospitals, Special | 1 | 2010 | 9 | 0.370 |
Why?
| Airway Obstruction | 3 | 2018 | 51 | 0.370 |
Why?
| Cholesteatoma, Middle Ear | 2 | 2009 | 33 | 0.370 |
Why?
| Capillaries | 2 | 2022 | 58 | 0.370 |
Why?
| Cheek | 1 | 2010 | 9 | 0.370 |
Why?
| Lip | 1 | 2010 | 11 | 0.370 |
Why?
| Tracheal Neoplasms | 1 | 2009 | 9 | 0.360 |
Why?
| Multiple Endocrine Neoplasia Type 2a | 1 | 2009 | 6 | 0.360 |
Why?
| Cicatrix | 2 | 2020 | 43 | 0.350 |
Why?
| Carcinoma, Medullary | 1 | 2009 | 15 | 0.350 |
Why?
| Electrocoagulation | 2 | 2009 | 10 | 0.350 |
Why?
| Consensus | 3 | 2020 | 157 | 0.350 |
Why?
| Proteus mirabilis | 1 | 2009 | 2 | 0.350 |
Why?
| Bacteroidaceae Infections | 1 | 2009 | 2 | 0.350 |
Why?
| Proteus Infections | 1 | 2009 | 4 | 0.350 |
Why?
| Bacteroides | 1 | 2009 | 15 | 0.350 |
Why?
| Brain Abscess | 1 | 2009 | 11 | 0.350 |
Why?
| Immunohistochemistry | 4 | 2015 | 1090 | 0.350 |
Why?
| Otitis Media, Suppurative | 1 | 2009 | 8 | 0.350 |
Why?
| Cerebellar Diseases | 1 | 2009 | 18 | 0.350 |
Why?
| Proto-Oncogene Proteins c-ret | 1 | 2009 | 35 | 0.340 |
Why?
| Combined Modality Therapy | 5 | 2018 | 693 | 0.340 |
Why?
| Vomiting | 2 | 2021 | 73 | 0.340 |
Why?
| Child Development | 1 | 2010 | 204 | 0.340 |
Why?
| Quality Improvement | 2 | 2021 | 245 | 0.330 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 206 | 0.330 |
Why?
| Injections, Intralesional | 2 | 2021 | 38 | 0.330 |
Why?
| Electrosurgery | 1 | 2008 | 10 | 0.330 |
Why?
| Fibrin Tissue Adhesive | 1 | 2008 | 12 | 0.320 |
Why?
| Tracheotomy | 2 | 2019 | 14 | 0.320 |
Why?
| Skin, Artificial | 1 | 2007 | 9 | 0.310 |
Why?
| Hearing Loss, Unilateral | 3 | 2013 | 12 | 0.310 |
Why?
| Time Factors | 6 | 2020 | 3210 | 0.310 |
Why?
| MicroRNAs | 2 | 2023 | 386 | 0.300 |
Why?
| Fasciitis, Necrotizing | 1 | 2006 | 6 | 0.300 |
Why?
| Thyroid Neoplasms | 1 | 2009 | 162 | 0.300 |
Why?
| Atlanto-Axial Joint | 1 | 2006 | 6 | 0.300 |
Why?
| Risk Factors | 7 | 2020 | 3937 | 0.290 |
Why?
| Emphysema | 1 | 2006 | 15 | 0.290 |
Why?
| Tomography, X-Ray Computed | 6 | 2015 | 1222 | 0.290 |
Why?
| Arytenoid Cartilage | 2 | 2020 | 5 | 0.280 |
Why?
| Diet | 1 | 2010 | 598 | 0.280 |
Why?
| Photography | 2 | 2020 | 39 | 0.280 |
Why?
| Disease Management | 3 | 2019 | 184 | 0.280 |
Why?
| Bone Conduction | 3 | 2017 | 25 | 0.280 |
Why?
| Tinnitus | 1 | 2006 | 62 | 0.270 |
Why?
| Recurrence | 5 | 2016 | 692 | 0.270 |
Why?
| Esophagoscopy | 2 | 2020 | 26 | 0.270 |
Why?
| Esophagus | 3 | 2020 | 80 | 0.270 |
Why?
| Transcranial Magnetic Stimulation | 1 | 2006 | 81 | 0.270 |
Why?
| Reoperation | 5 | 2014 | 453 | 0.260 |
Why?
| Radiography | 2 | 2018 | 526 | 0.260 |
Why?
| Fellowships and Scholarships | 2 | 2016 | 117 | 0.240 |
Why?
| Gene Expression Regulation | 2 | 2020 | 1063 | 0.240 |
Why?
| Pediatrics | 2 | 2019 | 323 | 0.230 |
Why?
| Cross-Sectional Studies | 3 | 2022 | 1696 | 0.230 |
Why?
| Single-Blind Method | 2 | 2020 | 120 | 0.230 |
Why?
| Genetic Predisposition to Disease | 3 | 2019 | 570 | 0.230 |
Why?
| Diagnostic Imaging | 2 | 2017 | 185 | 0.230 |
Why?
| Patient Selection | 2 | 2019 | 284 | 0.230 |
Why?
| Antigens, Nuclear | 2 | 2013 | 24 | 0.220 |
Why?
| Transplantation, Heterologous | 2 | 2013 | 76 | 0.220 |
Why?
| Cohort Studies | 5 | 2020 | 1546 | 0.220 |
Why?
| Treatment Failure | 2 | 2016 | 141 | 0.220 |
Why?
| Mandible | 1 | 2023 | 24 | 0.220 |
Why?
| Tracheal Stenosis | 2 | 2015 | 10 | 0.220 |
Why?
| Esthetics, Dental | 1 | 2022 | 21 | 0.220 |
Why?
| Magnetic Resonance Imaging | 5 | 2015 | 1616 | 0.220 |
Why?
| Internship and Residency | 2 | 2020 | 501 | 0.220 |
Why?
| Vocal Cords | 1 | 2022 | 12 | 0.220 |
Why?
| Transforming Growth Factor beta1 | 1 | 2022 | 66 | 0.210 |
Why?
| Mice, Nude | 2 | 2013 | 284 | 0.210 |
Why?
| Disease Progression | 3 | 2011 | 915 | 0.210 |
Why?
| Nevus, Blue | 1 | 2022 | 13 | 0.210 |
Why?
| Immunoenzyme Techniques | 2 | 2013 | 166 | 0.210 |
Why?
| Respiratory Sounds | 2 | 2019 | 54 | 0.210 |
Why?
| Prognosis | 3 | 2018 | 2126 | 0.210 |
Why?
| Comorbidity | 3 | 2015 | 664 | 0.210 |
Why?
| Gastrointestinal Neoplasms | 1 | 2022 | 46 | 0.210 |
Why?
| Case-Control Studies | 2 | 2017 | 1229 | 0.200 |
Why?
| Nausea | 1 | 2021 | 53 | 0.190 |
Why?
| Air Microbiology | 1 | 2020 | 12 | 0.190 |
Why?
| Operating Rooms | 1 | 2021 | 40 | 0.190 |
Why?
| Mouth Mucosa | 1 | 2020 | 31 | 0.190 |
Why?
| Efficiency, Organizational | 1 | 2021 | 53 | 0.190 |
Why?
| Animals | 7 | 2019 | 14409 | 0.190 |
Why?
| Thrombelastography | 1 | 2020 | 28 | 0.190 |
Why?
| Middle Aged | 8 | 2022 | 13082 | 0.190 |
Why?
| DiGeorge Syndrome | 1 | 2020 | 20 | 0.190 |
Why?
| Hemostasis | 1 | 2020 | 55 | 0.190 |
Why?
| LIM Domain Proteins | 1 | 2020 | 8 | 0.190 |
Why?
| Retinal Dehydrogenase | 1 | 2020 | 10 | 0.190 |
Why?
| Myosin Type I | 1 | 2020 | 5 | 0.190 |
Why?
| Antiporters | 1 | 2020 | 19 | 0.190 |
Why?
| Receptors, Notch | 1 | 2020 | 27 | 0.180 |
Why?
| Reference Values | 2 | 2011 | 354 | 0.180 |
Why?
| Hearing Loss, Conductive | 2 | 2011 | 52 | 0.180 |
Why?
| Pain, Postoperative | 1 | 2021 | 160 | 0.180 |
Why?
| Parasomnias | 1 | 2019 | 4 | 0.180 |
Why?
| Mastoid | 3 | 2009 | 51 | 0.180 |
Why?
| Microsurgery | 2 | 2011 | 35 | 0.180 |
Why?
| Tertiary Care Centers | 1 | 2020 | 83 | 0.180 |
Why?
| Cytoskeletal Proteins | 1 | 2020 | 58 | 0.180 |
Why?
| Physician Assistants | 1 | 2019 | 20 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 3 | 2013 | 1476 | 0.180 |
Why?
| Diagnosis, Differential | 3 | 2019 | 1141 | 0.180 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 44 | 0.180 |
Why?
| Surgical Wound Infection | 1 | 2020 | 126 | 0.180 |
Why?
| Elastic Tissue | 1 | 2019 | 10 | 0.180 |
Why?
| Analysis of Variance | 2 | 2014 | 634 | 0.170 |
Why?
| Tetralogy of Fallot | 1 | 2020 | 94 | 0.170 |
Why?
| Ambulatory Care | 1 | 2021 | 231 | 0.170 |
Why?
| Rats, Sprague-Dawley | 3 | 2009 | 1664 | 0.170 |
Why?
| Neovascularization, Pathologic | 1 | 2020 | 168 | 0.170 |
Why?
| Nurse Practitioners | 1 | 2019 | 45 | 0.170 |
Why?
| Endothelium, Vascular | 1 | 2021 | 288 | 0.170 |
Why?
| Continuous Positive Airway Pressure | 1 | 2019 | 58 | 0.170 |
Why?
| Mitochondrial Proteins | 1 | 2020 | 121 | 0.170 |
Why?
| Professional Role | 1 | 2019 | 88 | 0.170 |
Why?
| Tryptases | 1 | 2018 | 4 | 0.170 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 208 | 0.170 |
Why?
| Microcirculation | 1 | 2019 | 89 | 0.170 |
Why?
| Sirolimus | 1 | 2019 | 65 | 0.170 |
Why?
| p120 GTPase Activating Protein | 1 | 2018 | 1 | 0.170 |
Why?
| Dexamethasone | 1 | 2021 | 435 | 0.170 |
Why?
| Port-Wine Stain | 1 | 2018 | 14 | 0.160 |
Why?
| Fibrosis | 1 | 2019 | 209 | 0.160 |
Why?
| Age Factors | 3 | 2013 | 1199 | 0.160 |
Why?
| Estrogen Receptor beta | 1 | 2018 | 56 | 0.160 |
Why?
| Constriction, Pathologic | 1 | 2018 | 104 | 0.160 |
Why?
| Cryosurgery | 1 | 2018 | 38 | 0.160 |
Why?
| Random Allocation | 2 | 2009 | 312 | 0.160 |
Why?
| Airway Extubation | 1 | 2018 | 38 | 0.160 |
Why?
| Estrogen Receptor alpha | 1 | 2018 | 95 | 0.160 |
Why?
| Protein Transport | 1 | 2018 | 195 | 0.160 |
Why?
| Optical Phenomena | 1 | 2017 | 11 | 0.160 |
Why?
| Ultrasonography, Doppler | 1 | 2018 | 57 | 0.160 |
Why?
| Palatine Tonsil | 1 | 2017 | 12 | 0.160 |
Why?
| Neovascularization, Physiologic | 2 | 2009 | 72 | 0.160 |
Why?
| Nanomedicine | 1 | 2017 | 22 | 0.160 |
Why?
| Constipation | 1 | 2017 | 34 | 0.150 |
Why?
| Angiotensinogen | 1 | 2017 | 12 | 0.150 |
Why?
| Transcriptome | 1 | 2020 | 346 | 0.150 |
Why?
| Faculty, Medical | 2 | 2019 | 100 | 0.150 |
Why?
| Pressure | 1 | 2017 | 120 | 0.150 |
Why?
| Peptidyl-Dipeptidase A | 1 | 2017 | 25 | 0.150 |
Why?
| Pathology, Surgical | 1 | 2017 | 27 | 0.150 |
Why?
| Cadaver | 1 | 2017 | 113 | 0.150 |
Why?
| Antibiotics, Antineoplastic | 1 | 2018 | 85 | 0.150 |
Why?
| Diarrhea | 1 | 2017 | 90 | 0.150 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2017 | 61 | 0.150 |
Why?
| Intubation, Intratracheal | 1 | 2018 | 129 | 0.150 |
Why?
| Middle Ear Ventilation | 1 | 2016 | 14 | 0.150 |
Why?
| Otitis Media with Effusion | 1 | 2016 | 16 | 0.150 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 206 | 0.140 |
Why?
| Child Behavior Disorders | 1 | 2017 | 87 | 0.140 |
Why?
| Rats | 3 | 2009 | 3419 | 0.140 |
Why?
| Child Behavior | 1 | 2017 | 114 | 0.140 |
Why?
| Mice | 3 | 2013 | 6428 | 0.140 |
Why?
| Food Hypersensitivity | 1 | 2017 | 99 | 0.140 |
Why?
| Tobacco Smoke Pollution | 1 | 2016 | 56 | 0.140 |
Why?
| Serum | 1 | 2016 | 39 | 0.140 |
Why?
| Mitochondria | 1 | 2020 | 490 | 0.140 |
Why?
| Drug Administration Schedule | 2 | 2013 | 401 | 0.140 |
Why?
| Hearing Loss | 1 | 2017 | 85 | 0.130 |
Why?
| Nasopharyngeal Diseases | 1 | 2015 | 3 | 0.130 |
Why?
| Nasal Obstruction | 1 | 2015 | 16 | 0.130 |
Why?
| Anticoagulants | 1 | 2018 | 270 | 0.130 |
Why?
| Urinary Bladder | 1 | 2015 | 84 | 0.130 |
Why?
| Bandages, Hydrocolloid | 1 | 2014 | 4 | 0.130 |
Why?
| Delphi Technique | 3 | 2020 | 38 | 0.130 |
Why?
| Gels | 1 | 2014 | 19 | 0.130 |
Why?
| Inflammation | 1 | 2019 | 678 | 0.120 |
Why?
| North America | 1 | 2014 | 70 | 0.120 |
Why?
| Endoscopy, Digestive System | 1 | 2014 | 53 | 0.120 |
Why?
| Biopsy, Needle | 1 | 2015 | 195 | 0.120 |
Why?
| Early Diagnosis | 1 | 2014 | 96 | 0.120 |
Why?
| Foreign Bodies | 2 | 2020 | 64 | 0.120 |
Why?
| Sickness Impact Profile | 1 | 2014 | 35 | 0.120 |
Why?
| Term Birth | 1 | 2013 | 21 | 0.120 |
Why?
| Administration, Oral | 2 | 2018 | 461 | 0.120 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 37 | 0.120 |
Why?
| Apoptosis | 1 | 2020 | 1302 | 0.120 |
Why?
| Aged | 4 | 2022 | 10060 | 0.120 |
Why?
| Polysomnography | 1 | 2013 | 71 | 0.110 |
Why?
| Hospitals, University | 1 | 2013 | 89 | 0.110 |
Why?
| Bronchoscopy | 2 | 2010 | 79 | 0.110 |
Why?
| Actins | 1 | 2013 | 132 | 0.110 |
Why?
| Otologic Surgical Procedures | 2 | 2009 | 39 | 0.110 |
Why?
| Incidence | 2 | 2013 | 1083 | 0.110 |
Why?
| Lymphocele | 1 | 2011 | 7 | 0.100 |
Why?
| Antiviral Agents | 1 | 2013 | 188 | 0.100 |
Why?
| Pregnancy | 1 | 2019 | 2639 | 0.100 |
Why?
| Tissue Survival | 1 | 2011 | 12 | 0.100 |
Why?
| Algorithms | 1 | 2016 | 697 | 0.100 |
Why?
| Hearing Loss, Sensorineural | 1 | 2013 | 83 | 0.100 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 55 | 0.100 |
Why?
| Statistics, Nonparametric | 2 | 2014 | 232 | 0.100 |
Why?
| Tissue Culture Techniques | 1 | 2011 | 46 | 0.100 |
Why?
| Ultrasonography, Interventional | 1 | 2012 | 146 | 0.100 |
Why?
| Education, Medical, Graduate | 1 | 2014 | 226 | 0.100 |
Why?
| Internet | 1 | 2014 | 275 | 0.100 |
Why?
| Lymphocytosis | 1 | 2011 | 4 | 0.100 |
Why?
| Laryngeal Edema | 1 | 2011 | 5 | 0.100 |
Why?
| Arkansas | 3 | 2016 | 2100 | 0.100 |
Why?
| Hypertrophy | 1 | 2011 | 55 | 0.100 |
Why?
| Nutritional Support | 1 | 2010 | 35 | 0.100 |
Why?
| Infant, Premature | 1 | 2013 | 337 | 0.100 |
Why?
| Liver | 1 | 2017 | 1226 | 0.100 |
Why?
| Brain | 1 | 2019 | 1392 | 0.090 |
Why?
| Lip Neoplasms | 1 | 2010 | 4 | 0.090 |
Why?
| Auditory Threshold | 1 | 2010 | 46 | 0.090 |
Why?
| Tracheal Diseases | 1 | 2010 | 12 | 0.090 |
Why?
| Tongue Diseases | 1 | 2009 | 5 | 0.090 |
Why?
| Thyroglossal Cyst | 1 | 2009 | 4 | 0.090 |
Why?
| Hospitals, Teaching | 1 | 2010 | 58 | 0.090 |
Why?
| Medical Records | 1 | 2010 | 92 | 0.090 |
Why?
| Calcitonin | 1 | 2009 | 38 | 0.090 |
Why?
| Vincristine | 1 | 2009 | 98 | 0.090 |
Why?
| Sensory Thresholds | 1 | 2009 | 20 | 0.090 |
Why?
| Granulation Tissue | 1 | 2009 | 12 | 0.090 |
Why?
| Blood Flow Velocity | 2 | 2020 | 114 | 0.090 |
Why?
| Lymphotoxin-alpha | 1 | 2009 | 10 | 0.090 |
Why?
| Tympanic Membrane | 1 | 2009 | 39 | 0.090 |
Why?
| Physical Examination | 1 | 2009 | 99 | 0.090 |
Why?
| Turner Syndrome | 1 | 2008 | 14 | 0.080 |
Why?
| Mucous Membrane | 1 | 2009 | 33 | 0.080 |
Why?
| Rhinitis | 1 | 2009 | 33 | 0.080 |
Why?
| Neoplasm Invasiveness | 1 | 2010 | 294 | 0.080 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2009 | 87 | 0.080 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 116 | 0.080 |
Why?
| Transplantation, Homologous | 1 | 2009 | 154 | 0.080 |
Why?
| Infusions, Intravenous | 1 | 2009 | 231 | 0.080 |
Why?
| Burns, Electric | 1 | 2008 | 2 | 0.080 |
Why?
| Ear Diseases | 1 | 2008 | 25 | 0.080 |
Why?
| Sinusitis | 1 | 2009 | 60 | 0.080 |
Why?
| Suction | 1 | 2008 | 22 | 0.080 |
Why?
| Thyroidectomy | 1 | 2009 | 103 | 0.080 |
Why?
| Chi-Square Distribution | 1 | 2009 | 318 | 0.080 |
Why?
| Fires | 1 | 2008 | 19 | 0.080 |
Why?
| Shock, Septic | 1 | 2009 | 80 | 0.080 |
Why?
| Photomicrography | 1 | 2007 | 7 | 0.080 |
Why?
| Sleep Apnea Syndromes | 1 | 2008 | 31 | 0.080 |
Why?
| Factor VII | 1 | 2007 | 3 | 0.080 |
Why?
| Mouth Floor | 1 | 2007 | 5 | 0.080 |
Why?
| Polyvinyl Alcohol | 1 | 2007 | 7 | 0.080 |
Why?
| Biocompatible Materials | 1 | 2007 | 65 | 0.070 |
Why?
| Neoplasm Staging | 1 | 2010 | 805 | 0.070 |
Why?
| Postoperative Care | 1 | 2008 | 121 | 0.070 |
Why?
| Collateral Circulation | 1 | 2007 | 41 | 0.070 |
Why?
| Hospitals, Pediatric | 2 | 2019 | 270 | 0.070 |
Why?
| Auditory Cortex | 1 | 2006 | 21 | 0.070 |
Why?
| Intraoperative Complications | 1 | 2008 | 125 | 0.070 |
Why?
| Therapy, Computer-Assisted | 1 | 2006 | 34 | 0.070 |
Why?
| Thalamus | 1 | 2006 | 33 | 0.070 |
Why?
| Angiography | 1 | 2007 | 148 | 0.070 |
Why?
| Patient Satisfaction | 1 | 2008 | 302 | 0.070 |
Why?
| Arousal | 1 | 2006 | 105 | 0.070 |
Why?
| Swine | 1 | 2007 | 430 | 0.070 |
Why?
| Phenotype | 2 | 2019 | 819 | 0.070 |
Why?
| Psychomotor Performance | 1 | 2006 | 156 | 0.070 |
Why?
| Reaction Time | 1 | 2006 | 227 | 0.070 |
Why?
| Preoperative Care | 1 | 2007 | 184 | 0.070 |
Why?
| Attention | 1 | 2006 | 185 | 0.070 |
Why?
| Radiopharmaceuticals | 1 | 2006 | 242 | 0.060 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2006 | 212 | 0.060 |
Why?
| Chronic Disease | 3 | 2016 | 614 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2009 | 543 | 0.060 |
Why?
| Positron-Emission Tomography | 1 | 2006 | 323 | 0.060 |
Why?
| United States | 4 | 2016 | 5208 | 0.060 |
Why?
| Otitis Media | 2 | 2016 | 30 | 0.060 |
Why?
| Mice, Inbred C57BL | 1 | 2009 | 2001 | 0.060 |
Why?
| Growth Differentiation Factor 2 | 1 | 2022 | 6 | 0.060 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2023 | 96 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2009 | 825 | 0.060 |
Why?
| Mutation | 2 | 2019 | 1504 | 0.050 |
Why?
| Transforming Growth Factor beta | 1 | 2022 | 158 | 0.050 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2022 | 80 | 0.050 |
Why?
| Esophagoscopes | 1 | 2020 | 1 | 0.050 |
Why?
| Blood Coagulation Tests | 1 | 2020 | 23 | 0.050 |
Why?
| Blood Coagulation | 1 | 2020 | 69 | 0.050 |
Why?
| Gastrostomy | 1 | 2020 | 60 | 0.050 |
Why?
| Exhalation | 1 | 2019 | 19 | 0.050 |
Why?
| Embryonic Development | 1 | 2019 | 17 | 0.050 |
Why?
| Ligands | 1 | 2020 | 229 | 0.050 |
Why?
| Genetic Loci | 1 | 2019 | 58 | 0.040 |
Why?
| Risk | 1 | 2020 | 343 | 0.040 |
Why?
| Fetus | 1 | 2021 | 228 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2019 | 95 | 0.040 |
Why?
| Income | 1 | 2019 | 102 | 0.040 |
Why?
| Syndrome | 1 | 2019 | 253 | 0.040 |
Why?
| Genetic Association Studies | 1 | 2019 | 136 | 0.040 |
Why?
| Hemorrhage | 1 | 2020 | 209 | 0.040 |
Why?
| Angiogenesis Inhibitors | 1 | 2020 | 203 | 0.040 |
Why?
| Double-Blind Method | 1 | 2020 | 743 | 0.040 |
Why?
| Gene Expression | 1 | 2021 | 664 | 0.040 |
Why?
| Comparative Genomic Hybridization | 1 | 2018 | 50 | 0.040 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2018 | 11 | 0.040 |
Why?
| Fibrinogen | 1 | 2018 | 37 | 0.040 |
Why?
| Tertiary Healthcare | 1 | 2017 | 19 | 0.040 |
Why?
| DNA-Binding Proteins | 1 | 2020 | 462 | 0.040 |
Why?
| Transcription Factors | 1 | 2020 | 622 | 0.040 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 291 | 0.030 |
Why?
| Triage | 1 | 2016 | 76 | 0.030 |
Why?
| Quality-Adjusted Life Years | 1 | 2015 | 70 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 643 | 0.030 |
Why?
| Pain | 1 | 2018 | 405 | 0.030 |
Why?
| Odds Ratio | 1 | 2016 | 600 | 0.030 |
Why?
| Patient-Centered Care | 1 | 2016 | 132 | 0.030 |
Why?
| Job Application | 1 | 2014 | 12 | 0.030 |
Why?
| Personnel Selection | 1 | 2014 | 28 | 0.030 |
Why?
| Logistic Models | 1 | 2016 | 991 | 0.030 |
Why?
| Personal Satisfaction | 1 | 2014 | 90 | 0.030 |
Why?
| Temporal Bone | 1 | 2013 | 35 | 0.030 |
Why?
| Patient Care Team | 1 | 2015 | 273 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2016 | 489 | 0.030 |
Why?
| Oximetry | 1 | 2013 | 62 | 0.030 |
Why?
| Patient Admission | 1 | 2013 | 78 | 0.030 |
Why?
| Program Evaluation | 1 | 2014 | 379 | 0.030 |
Why?
| Societies, Medical | 1 | 2013 | 195 | 0.030 |
Why?
| Decision Making | 1 | 2014 | 286 | 0.020 |
Why?
| Electrocardiography | 1 | 2013 | 290 | 0.020 |
Why?
| Referral and Consultation | 1 | 2013 | 308 | 0.020 |
Why?
| Suture Anchors | 1 | 2010 | 15 | 0.020 |
Why?
| Fiber Optic Technology | 1 | 2010 | 17 | 0.020 |
Why?
| Blood Pressure | 1 | 2013 | 587 | 0.020 |
Why?
| Blood Glucose | 1 | 2013 | 489 | 0.020 |
Why?
| Prolapse | 1 | 2009 | 7 | 0.020 |
Why?
| Safety | 1 | 2010 | 92 | 0.020 |
Why?
| Equipment Design | 1 | 2010 | 318 | 0.020 |
Why?
| Ear, Middle | 1 | 2008 | 17 | 0.020 |
Why?
| Demography | 1 | 2009 | 103 | 0.020 |
Why?
| Electric Power Supplies | 1 | 2008 | 1 | 0.020 |
Why?
| Drainage | 1 | 2008 | 79 | 0.020 |
Why?
| Acute Disease | 1 | 2009 | 403 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2015 | 3431 | 0.020 |
Why?
| Factor VIIa | 1 | 2007 | 10 | 0.020 |
Why?
| Postoperative Hemorrhage | 1 | 2007 | 53 | 0.020 |
Why?
| Survival Rate | 1 | 2008 | 954 | 0.020 |
Why?
| Length of Stay | 1 | 2009 | 683 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2007 | 570 | 0.020 |
Why?
|
|
Richter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|